Prostate-specific membrane antigen (PSMA) targeted PET is a new molecular imaging method for identifying and quantifying sites of prostate cancer disease, especially for detecting biochemical recurrences after initial therapy [16, 17]. The gene discussed is FOLH1; the disease is prostate cancer.